BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2026 2:09:41 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-05-18 09:31 |
|
Peer-Review Started |
|
2026-05-18 09:31 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-07-05 09:04 |
|
Revised |
|
2026-07-17 08:55 |
|
Publication Fee Transferred |
|
2026-08-06 02:05 |
|
Second Decision by Editor |
|
2026-09-14 03:05 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-09-15 09:27 |
|
Articles in Press |
|
2026-09-15 09:27 |
|
Edit the Manuscript by Language Editor |
|
2026-09-17 09:19 |
|
Typeset the Manuscript |
|
2026-10-12 01:24 |
|
Publish the Manuscript Online |
|
2026-10-21 02:09 |
| ISSN |
1948-5182 (online) |
| Open Access |
Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Translational Research |
| Article Title |
Cost-utility analysis of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease in Thailand
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sirada Limwongse, Paninnuch Chatpattanasiri, Phonnaphat Phuphuang, Krisada Tungthaweethong, Keerati Sutheerayongprasert, Watkornphat Aunprom-Me, Chayanis Kositamongkol and Pochamana Phisalprapa |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Pochamana Phisalprapa, Associate Professor, Lecturer, MD, PhD, Senior Researcher, Division of Ambulatory Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, No. 2 Wanglang Road, Siriraj, Bangkok Noi, Bangkok 10700, Thailand. pochamana.phi@mahidol.ac.th |
| Key Words |
Cost-utility analysis; Diabetes mellitus; Glucagon-like peptide-1 receptor agonists; Metabolic dysfunction-associated steatotic liver disease; Thailand |
| Core Tip |
This cost-utility analysis evaluated semaglutide and liraglutide for adults with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease in Thailand. Using a lifetime Markov model, we found that the incremental cost-effectiveness ratios of both drugs, relative to usual care, exceeded the national willingness-to-pay threshold. Neither drug was therefore cost-effective. Achieving cost-effectiveness would require price reductions exceeding 90%. These findings underscore the urgent need for drug price negotiations to improve treatment access within Thailand’s healthcare system. |
| Publish Date |
2026-10-21 02:09 |
| Citation |
Limwongse S, Chatpattanasiri P, Phuphuang P, Tungthaweethong K, Sutheerayongprasert K, Aunprom-Me W, Kositamongkol C, Phisalprapa P. Cost-utility analysis of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease in Thailand. World J Hepatol 2026; 18(10): 123353
|
| URL |
https://www.wjgnet.com/1948-5182/full/v18/i10/123353.htm |
| DOI |
https://doi.org/10.4254/wjh.123353 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
